PMC:7594251 / 184-365 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T7999","span":{"begin":174,"end":179},"obj":"Body_part"}],"attributes":[{"id":"A19488","pred":"fma_id","subj":"T7999","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"event a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells a"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":51,"end":61},"obj":"Disease"},{"id":"T2","span":{"begin":167,"end":173},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"event a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells a"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T32708","span":{"begin":6,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T17685","span":{"begin":22,"end":27},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T97528","span":{"begin":72,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T35994","span":{"begin":174,"end":179},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"event a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells a"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":150,"end":154},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"event a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells a"}

{"project":"LitCovid-PubTator","denotations":[{"id":"7","span":{"begin":22,"end":27},"obj":"Species"},{"id":"9","span":{"begin":51,"end":61},"obj":"Disease"},{"id":"10","span":{"begin":167,"end":173},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"Tax:9606"},{"id":"A9","pred":"tao:has_database_id","subj":"9","obj":"MESH:D007239"},{"id":"A10","pred":"tao:has_database_id","subj":"10","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"event a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells a"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T77349","span":{"begin":150,"end":165},"obj":"http://purl.obolibrary.org/obo/GO_0042493"}],"text":"event a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells a"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":150,"end":165},"obj":"Phenotype"},{"id":"T2","span":{"begin":167,"end":173},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0020174"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"event a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells a"}

{"project":"LitCovid-sentences","denotations":[{"id":"T4","span":{"begin":41,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"event a wide range of human pathologies. Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. Cancer cells a"}